Ernexa Therapeutics (ERNAW) Interest Expenses (2022 - 2023)
Ernexa Therapeutics (ERNAW) reported Interest Expenses of $245000.0 for Q4 2023, up 121.57% on a YoY basis from $110576.1 in Q4 2022, and up 114.91% quarter-over-quarter from $114000.0 in Q3 2023.
Ernexa Therapeutics (ERNAW) Interest Expenses (2022 - 2023) Analysis & Trends
Ernexa Therapeutics has reported Interest Expenses for 2 years, with the latest figure at $245000.0 in Q4 2023.
- For the quarter ending Q4 2023, Interest Expenses rose 121.57% year-over-year to $245000.0; the trailing twelve-month figure through Sep 2024 stood at $245000.0 (up 131.98% YoY), and the FY2023 full-year result was $614000.0, up 1946.67% from the prior year.
- Interest Expenses for Q4 2023 stood at $245000.0, up from $114000.0 in the prior quarter.
- The five-year high for Interest Expenses was $256000.0 in Q2 2023, with the low at -$1.1 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Ernexa Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 245,000.00 |
| Dec 31, 2023 | 245,000.00 |
| Sep 30, 2023 | 114,000.00 |
| Sep 30, 2023 | 114,000.00 |
| Jun 30, 2023 | 256,000.00 |
| Jun 30, 2023 | 256,000.00 |
| Dec 31, 2022 | -1.14 Mn |
| Dec 31, 2022 | -1.14 Mn |
| Sep 30, 2022 | 10,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 14,000.00 |